Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

I-Mab Announces IND Clearance to Treat COVID-19 Cytokine Release Syndrome

americanpharmaceuticalreviewApril 09, 2020

Tag: I-Mab , COVID-19 , cytokine release syndrome , TJM2

PharmaSources Customer Service